Base de dados : MEDLINE
Pesquisa : N03.540.630.780.110 [Categoria DeCS]
Referências encontradas : 2208 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 221 ir para página                         

  1 / 2208 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29242938
[Au] Autor:Greenland P
[Ad] Endereço:Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
[Ti] Título:Cardiovascular Guideline Skepticism vs Lifestyle Realism?
[So] Source:JAMA;319(2):117-118, 2018 Jan 09.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Doenças Cardiovasculares
Hipercolesterolemia
Hipertensão
Guias de Prática Clínica como Assunto
[Mh] Termos MeSH secundário: American Heart Association
Seres Humanos
Valores de Referência
Fatores de Risco
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180123
[Lr] Data última revisão:
180123
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171216
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2017.19675


  2 / 2208 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29242891
[Au] Autor:Ioannidis JPA
[Ad] Endereço:Stanford Prevention Research Center, Meta-Research Innovation Center at Stanford (METRICS), and Departments of Medicine, Health Research and Policy, Biomedical Data Science, and Statistics, Stanford University, Stanford, California.
[Ti] Título:Diagnosis and Treatment of Hypertension in the 2017 ACC/AHA Guidelines and in the Real World.
[So] Source:JAMA;319(2):115-116, 2018 Jan 09.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Anti-Hipertensivos/uso terapêutico
Hipertensão/diagnóstico
Hipertensão/tratamento farmacológico
Guias de Prática Clínica como Assunto
[Mh] Termos MeSH secundário: Adulto
Idoso
American Heart Association
Pressão Sanguínea
Seres Humanos
Meia-Idade
Valores de Referência
Sociedades Médicas
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antihypertensive Agents)
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180123
[Lr] Data última revisão:
180123
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171216
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2017.19672


  3 / 2208 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27777359
[Au] Autor:Bromfield SG; Shimbo D; Booth JN; Correa A; Ogedegbe G; Carson AP; Muntner P
[Ad] Endereço:From the Department of Epidemiology, University of Alabama at Birmingham (S.G.B., J.N.B., A.P.C., P.M.); Department of Medicine, Columbia University Medical Center, New York, NY (D.S.); Department of Medicine, University of Mississippi Medical Center, Jackson (A.C.); and Department of Population Hea
[Ti] Título:Cardiovascular Risk Factors and Masked Hypertension: The Jackson Heart Study.
[So] Source:Hypertension;68(6):1475-1482, 2016 12.
[Is] ISSN:1524-4563
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Masked hypertension is associated with increased risk for cardiovascular disease. Identifying modifiable risk factors for masked hypertension could provide approaches to reduce its prevalence. Life's Simple 7 is a measure of cardiovascular health developed by the American Heart Association that includes body mass index, physical activity, diet, cigarette smoking, blood pressure (BP), cholesterol, and glucose. We examined the association between cardiovascular health and masked daytime hypertension in the Jackson Heart Study, an exclusively African American cohort. Life's Simple 7 factors were assessed during a study visit and categorized as poor, intermediate, or ideal. Ambulatory BP monitoring was performed after the study visit. Using BP measured between 10:00 am and 8:00 pm on ambulatory BP monitoring, masked daytime hypertension was defined as mean clinic systolic BP/diastolic BP <140/90 mm Hg and mean daytime systolic BP/diastolic BP ≥135/85 mm Hg. Among the 758 participants with systolic BP/diastolic BP <140/90 mm Hg, 30.5% had masked daytime hypertension. The multivariable-adjusted prevalence ratios for masked daytime hypertension comparing participants with 2, 3, and ≥4 versus ≤1 ideal Life's Simple 7 factors were 0.99 (95% confidence interval [CI], 0.74-1.33), 0.77 (95% CI, 0.57-1.03), and 0.51 (95% CI, 0.33-0.79), respectively. Masked daytime hypertension was less common among participants with ideal versus poor levels of physical activity (ratio, 0.74; 95% CI, 0.56-1.00), ideal or intermediate levels pooled together versus poor diet (prevalence ratio, 0.73; 95% CI, 0.58-0.91), ideal versus poor levels of cigarette smoking (prevalence ratio, 0.61; 95% CI, 0.46-0.82), and ideal versus intermediate levels of clinic BP (prevalence ratio, 0.28, 95% CI, 0.16-0.48). Better cardiovascular health is associated with a lower preva lence of masked hypertension.
[Mh] Termos MeSH primário: Afroamericanos/estatística & dados numéricos
Doenças Cardiovasculares/etiologia
Hipertensão Mascarada/complicações
Hipertensão Mascarada/diagnóstico
Inquéritos e Questionários
[Mh] Termos MeSH secundário: American Heart Association
Monitorização Ambulatorial da Pressão Arterial
Doenças Cardiovasculares/fisiopatologia
Ritmo Circadiano
Estudos Transversais
Feminino
Seres Humanos
Masculino
Hipertensão Mascarada/etnologia
Meia-Idade
Prevalência
Prognóstico
Medição de Risco
Índice de Gravidade de Doença
Distribuição por Sexo
Fumar/efeitos adversos
Fumar/epidemiologia
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL
[Em] Mês de entrada:1708
[Cu] Atualização por classe:180112
[Lr] Data última revisão:
180112
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161026
[St] Status:MEDLINE


  4 / 2208 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29242239
[Au] Autor:Shaw LJ; Blankstein R; Jacobs JE; Leipsic JA; Kwong RY; Taqueti VR; Beanlands RSB; Mieres JH; Flamm SD; Gerber TC; Spertus J; Di Carli MF; American Heart Association Cardiovascular Imaging and Intervention Subcommittee of the Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Disease in the Young; and Council on Quality of Care and Outcomes Research
[Ti] Título:Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association.
[So] Source:Circ Cardiovasc Imaging;10(12), 2017 Dec.
[Is] ISSN:1942-0080
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The aims of the current statement are to refine the definition of quality in cardiovascular imaging and to propose novel methodological approaches to inform the demonstration of quality in imaging in future clinical trials and registries. We propose defining quality in cardiovascular imaging using an analytical framework put forth by the Institute of Medicine whereby quality was defined as testing being safe, effective, patient-centered, timely, equitable, and efficient. The implications of each of these components of quality health care are as essential for cardiovascular imaging as they are for other areas within health care. Our proposed statement may serve as the foundation for integrating these quality indicators into establishing designations of quality laboratory practices and developing standards for value-based payment reform for imaging services. We also include recommendations for future clinical research to fulfill quality aims within cardiovascular imaging, including clinical hypotheses of improving patient outcomes, the importance of health status as an end point, and deferred testing options. Future research should evolve to define novel methods optimized for the role of cardiovascular imaging for detecting disease and guiding treatment and to demonstrate the role of cardiovascular imaging in facilitating healthcare quality.
[Mh] Termos MeSH primário: Doenças Cardiovasculares/diagnóstico por imagem
Diagnóstico por Imagem/normas
Qualidade da Assistência à Saúde
[Mh] Termos MeSH secundário: American Heart Association
Seres Humanos
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171226
[Lr] Data última revisão:
171226
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171216
[St] Status:MEDLINE


  5 / 2208 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28974521
[Au] Autor:Sandau KE; Funk M; Auerbach A; Barsness GW; Blum K; Cvach M; Lampert R; May JL; McDaniel GM; Perez MV; Sendelbach S; Sommargren CE; Wang PJ; American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Cardiovascular Disease in the Young
[Ti] Título:Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association.
[So] Source:Circulation;136(19):e273-e344, 2017 Nov 07.
[Is] ISSN:1524-4539
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND AND PURPOSE: This scientific statement provides an interprofessional, comprehensive review of evidence and recommendations for indications, duration, and implementation of continuous electro cardiographic monitoring of hospitalized patients. Since the original practice standards were published in 2004, new issues have emerged that need to be addressed: overuse of arrhythmia monitoring among a variety of patient populations, appropriate use of ischemia and QT-interval monitoring among select populations, alarm management, and documentation in electronic health records. METHODS: Authors were commissioned by the American Heart Association and included experts from general cardiology, electrophysiology (adult and pediatric), and interventional cardiology, as well as a hospitalist and experts in alarm management. Strict adherence to the American Heart Association conflict of interest policy was maintained throughout the consensus process. Authors were assigned topics relevant to their areas of expertise, reviewed the literature with an emphasis on publications since the prior practice standards, and drafted recommendations on indications and duration for electrocardiographic monitoring in accordance with the American Heart Association Level of Evidence grading algorithm that was in place at the time of commissioning. RESULTS: The comprehensive document is grouped into 5 sections: (1) Overview of Arrhythmia, Ischemia, and QTc Monitoring; (2) Recommendations for Indication and Duration of Electrocardiographic Monitoring presented by patient population; (3) Organizational Aspects: Alarm Management, Education of Staff, and Documentation; (4) Implementation of Practice Standards; and (5) Call for Research. CONCLUSIONS: Many of the recommendations are based on limited data, so authors conclude with specific questions for further research.
[Mh] Termos MeSH primário: American Heart Association
Arritmias Cardíacas/diagnóstico
Serviço Hospitalar de Cardiologia/normas
Eletrocardiografia/normas
Hospitalização
[Mh] Termos MeSH secundário: Arritmias Cardíacas/fisiopatologia
Arritmias Cardíacas/terapia
Alarmes Clínicos/normas
Consenso
Documentação/normas
Eletrocardiografia Ambulatorial/normas
Registros Eletrônicos de Saúde/normas
Medicina Baseada em Evidências/normas
Teste de Esforço/normas
Controle de Formulários e Registros/normas
Seres Humanos
Valor Preditivo dos Testes
Prognóstico
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; PRACTICE GUIDELINE; REVIEW
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171113
[Lr] Data última revisão:
171113
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171005
[St] Status:MEDLINE
[do] DOI:10.1161/CIR.0000000000000527


  6 / 2208 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28923988
[Au] Autor:van Diepen S; Katz JN; Albert NM; Henry TD; Jacobs AK; Kapur NK; Kilic A; Menon V; Ohman EM; Sweitzer NK; Thiele H; Washam JB; Cohen MG; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline
[Ti] Título:Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.
[So] Source:Circulation;136(16):e232-e268, 2017 Oct 17.
[Is] ISSN:1524-4539
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state of end-organ hypoperfusion that is frequently associated with multisystem organ failure. Despite improving survival in recent years, patient morbidity and mortality remain high, and there are few evidence-based therapeutic interventions known to clearly improve patient outcomes. This scientific statement on cardiogenic shock summarizes the epidemiology, pathophysiology, causes, and outcomes of cardiogenic shock; reviews contemporary best medical, surgical, mechanical circulatory support, and palliative care practices; advocates for the development of regionalized systems of care; and outlines future research priorities.
[Mh] Termos MeSH primário: American Heart Association
Hemodinâmica
Choque Cardiogênico/terapia
[Mh] Termos MeSH secundário: Prestação Integrada de Cuidados de Saúde/organização & administração
Custos de Cuidados de Saúde
Seres Humanos
Seleção de Pacientes
Fenótipo
Valor Preditivo dos Testes
Regionalização/organização & administração
Fatores de Risco
Choque Cardiogênico/diagnóstico
Choque Cardiogênico/epidemiologia
Choque Cardiogênico/fisiopatologia
Resultado do Tratamento
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171024
[Lr] Data última revisão:
171024
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170920
[St] Status:MEDLINE
[do] DOI:10.1161/CIR.0000000000000525


  7 / 2208 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28883125
[Au] Autor:Gorelick PB; Furie KL; Iadecola C; Smith EE; Waddy SP; Lloyd-Jones DM; Bae HJ; Bauman MA; Dichgans M; Duncan PW; Girgus M; Howard VJ; Lazar RM; Seshadri S; Testai FD; van Gaal S; Yaffe K; Wasiak H; Zerna C; American Heart Association/American Stroke Association
[Ad] Endereço:Also a member of Maintenance of Brain Health writing group section. Also a member of Optimal Brain Health writing group section. Lead of Maintenance of Brain Health writing group section. Lead of Public Health Impact of Cognitive Impairment, Dementia, Stroke, and Cardiovascular and Stroke Risks writ
[Ti] Título:Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association.
[So] Source:Stroke;48(10):e284-e303, 2017 Oct.
[Is] ISSN:1524-4628
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Cognitive function is an important component of aging and predicts quality of life, functional independence, and risk of institutionalization. Advances in our understanding of the role of cardiovascular risks have shown them to be closely associated with cognitive impairment and dementia. Because many cardiovascular risks are modifiable, it may be possible to maintain brain health and to prevent dementia in later life. The purpose of this American Heart Association (AHA)/American Stroke Association presidential advisory is to provide an initial definition of optimal brain health in adults and guidance on how to maintain brain health. We identify metrics to define optimal brain health in adults based on inclusion of factors that could be measured, monitored, and modified. From these practical considerations, we identified 7 metrics to define optimal brain health in adults that originated from AHA's Life's Simple 7: 4 ideal health behaviors (nonsmoking, physical activity at goal levels, healthy diet consistent with current guideline levels, and body mass index <25 kg/m ) and 3 ideal health factors (untreated blood pressure <120/<80 mm Hg, untreated total cholesterol <200 mg/dL, and fasting blood glucose <100 mg/dL). In addition, in relation to maintenance of cognitive health, we recommend following previously published guidance from the AHA/American Stroke Association, Institute of Medicine, and Alzheimer's Association that incorporates control of cardiovascular risks and suggest social engagement and other related strategies. We define optimal brain health but recognize that the truly ideal circumstance may be uncommon because there is a continuum of brain health as demonstrated by AHA's Life's Simple 7. Therefore, there is opportunity to improve brain health through primordial prevention and other interventions. Furthermore, although cardiovascular risks align well with brain health, we acknowledge that other factors differing from those related to cardiovascular health may drive cognitive health. Defining optimal brain health in adults and its maintenance is consistent with the AHA's Strategic Impact Goal to improve cardiovascular health of all Americans by 20% and to reduce deaths resulting from cardiovascular disease and stroke by 20% by the year 2020. This work in defining optimal brain health in adults serves to provide the AHA/American Stroke Association with a foundation for a new strategic direction going forward in cardiovascular health promotion and disease prevention.
[Mh] Termos MeSH primário: Comitês Consultivos/normas
American Heart Association
Encéfalo/fisiologia
Comportamentos Relacionados com a Saúde/fisiologia
Promoção da Saúde/normas
Acidente Vascular Cerebral/prevenção & controle
[Mh] Termos MeSH secundário: Adulto
Transtornos Cognitivos/epidemiologia
Transtornos Cognitivos/fisiopatologia
Transtornos Cognitivos/prevenção & controle
Promoção da Saúde/métodos
Seres Humanos
Acidente Vascular Cerebral/epidemiologia
Acidente Vascular Cerebral/fisiopatologia
Estados Unidos/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171026
[Lr] Data última revisão:
171026
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170909
[St] Status:MEDLINE
[do] DOI:10.1161/STR.0000000000000148


  8 / 2208 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28838934
[Au] Autor:Feingold B; Mahle WT; Auerbach S; Clemens P; Domenighetti AA; Jefferies JL; Judge DP; Lal AK; Markham LW; Parks WJ; Tsuda T; Wang PJ; Yoo SJ; American Heart Association Pediatric Heart Failure Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; Council on Functional Genomics and Translational Biology; and Stroke Council
[Ti] Título:Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association.
[So] Source:Circulation;136(13):e200-e231, 2017 Sep 26.
[Is] ISSN:1524-4539
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:For many neuromuscular diseases (NMDs), cardiac disease represents a major cause of morbidity and mortality. The management of cardiac disease in NMDs is made challenging by the broad clinical heterogeneity that exists among many NMDs and by limited knowledge about disease-specific cardiovascular pathogenesis and course-modifying interventions. The overlay of compromise in peripheral muscle function and other organ systems, such as the lungs, also makes the simple application of endorsed adult or pediatric heart failure guidelines to the NMD population problematic. In this statement, we provide background on several NMDs in which there is cardiac involvement, highlighting unique features of NMD-associated myocardial disease that require clinicians to tailor their approach to prevention and treatment of heart failure. Undoubtedly, further investigations are required to best inform future guidelines on NMD-specific cardiovascular health risks, treatments, and outcomes.
[Mh] Termos MeSH primário: Cardiomiopatias/diagnóstico
Doenças Musculares/diagnóstico
Doenças Neuromusculares/diagnóstico
[Mh] Termos MeSH secundário: American Heart Association
Síndrome de Barth/diagnóstico
Síndrome de Barth/genética
Síndrome de Barth/metabolismo
Síndrome de Barth/patologia
Cardiomiopatias/complicações
Cardiomiopatias/patologia
Ataxia de Friedreich/diagnóstico
Ataxia de Friedreich/metabolismo
Ataxia de Friedreich/patologia
Seres Humanos
Doenças Musculares/metabolismo
Doenças Musculares/patologia
Distrofia Muscular do Cíngulo dos Membros/diagnóstico
Distrofia Muscular do Cíngulo dos Membros/metabolismo
Distrofia Muscular do Cíngulo dos Membros/patologia
Distrofia Muscular de Duchenne/diagnóstico
Distrofia Muscular de Duchenne/metabolismo
Distrofia Muscular de Duchenne/patologia
Distrofia Muscular de Emery-Dreifuss/diagnóstico
Distrofia Muscular de Emery-Dreifuss/metabolismo
Distrofia Muscular de Emery-Dreifuss/patologia
Miopatias Congênitas Estruturais/diagnóstico
Miopatias Congênitas Estruturais/genética
Miopatias Congênitas Estruturais/metabolismo
Miopatias Congênitas Estruturais/patologia
Distrofia Miotônica/diagnóstico
Distrofia Miotônica/metabolismo
Distrofia Miotônica/patologia
Doenças Neuromusculares/complicações
Doenças Neuromusculares/patologia
Fatores de Risco
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; PRACTICE GUIDELINE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171005
[Lr] Data última revisão:
171005
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170826
[St] Status:MEDLINE
[do] DOI:10.1161/CIR.0000000000000526


  9 / 2208 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28794273
[Au] Autor:Willey JZ; Voutsinas J; Sherzai A; Ma H; Bernstein L; Elkind MSV; Cheung YK; Wang SS
[Ad] Endereço:From the Departments of Neurology (J.Z.W., M.S.V.E.), Epidemiology (M.S.V.E.), and Biostatistics (Y.K.C.), Columbia University, New York; Department of Population Sciences, City of Hope, Duarte, CA (J.V., H.M., L.B., S.S.W.); and Department of Neurology, Cedars Sinai Medical Center, Los Angeles, CA
[Ti] Título:Trajectories in Leisure-Time Physical Activity and Risk of Stroke in Women in the California Teachers Study.
[So] Source:Stroke;48(9):2346-2352, 2017 Sep.
[Is] ISSN:1524-4628
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND AND PURPOSE: Whether changes in leisure-time physical activity (LTPA) over time are associated with lower risk of stroke is not well established. We examined the association between changes in self-reported LTPA 10 years apart, with risk of incident stroke in the CTS (California Teachers Study). We hypothesized that the risk of stroke would be lowest among those who remained active. METHODS: Sixty-one thousand two hundred and fifty-six CTS participants reported LTPA at 2 intensity levels (moderate and strenuous activity) at 2 time points (baseline 1995-96; 10-year follow-up 2005-2006). LTPA at each intensity level was categorized based on American Heart Association (AHA) recommendations (moderate, >150 minutes/week; strenuous, >75 minutes/week). Changes in LTPA were summarized as follows: (1) not meeting recommendations at both time points; (2) meeting recommendations only at follow-up; (3) meeting recommendations only at baseline; and (4) meeting recommendations at both time points. Incident strokes were identified through California state hospitalization records. Using multivariable Cox models, we examined the associations between changes in LTPA with incident stroke. RESULTS: Nine hundred and eighty-seven women were diagnosed with stroke who completed both questionnaires. Meeting AHA recommendations at both the time points was associated with a lower risk of all stroke (adjusted hazard ratio, 0.84; 95% confidence interval, 0.72-0.98). The protective effects for stroke were driven by meeting AHA recommendations for moderate activity and largely observed for ischemic strokes (adjusted hazard ratio, 0.70; 95% confidence interval, 0.55-0.88). CONCLUSIONS: Meeting AHA recommendations for moderate activity had a protective effect for reducing ischemic stroke risk. Participants who met AHA recommendations at baseline but not at follow-up, however, were not afforded reduced stroke risk.
[Mh] Termos MeSH primário: Exercício
Atividades de Lazer
Acidente Vascular Cerebral/epidemiologia
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
American Heart Association
California/epidemiologia
Feminino
Seguimentos
Fidelidade a Diretrizes
Seres Humanos
Incidência
Meia-Idade
Análise Multivariada
Modelos de Riscos Proporcionais
Risco
Professores Escolares
Autorrelato
Inquéritos e Questionários
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170926
[Lr] Data última revisão:
170926
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170811
[St] Status:MEDLINE
[do] DOI:10.1161/STROKEAHA.117.017465


  10 / 2208 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28784624
[Au] Autor:Rao G; Lopez-Jimenez F; Boyd J; D'Amico F; Durant NH; Hlatky MA; Howard G; Kirley K; Masi C; Powell-Wiley TM; Solomonides AE; West CP; Wessel J; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; and Stroke Council
[Ti] Título:Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association.
[So] Source:Circulation;136(10):e172-e194, 2017 Sep 05.
[Is] ISSN:1524-4539
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Meta-analyses are becoming increasingly popular, especially in the fields of cardiovascular disease prevention and treatment. They are often considered to be a reliable source of evidence for making healthcare decisions. Unfortunately, problems among meta-analyses such as the misapplication and misinterpretation of statistical methods and tests are long-standing and widespread. The purposes of this statement are to review key steps in the development of a meta-analysis and to provide recommendations that will be useful for carrying out meta-analyses and for readers and journal editors, who must interpret the findings and gauge methodological quality. To make the statement practical and accessible, detailed descriptions of statistical methods have been omitted. Based on a survey of cardiovascular meta-analyses, published literature on methodology, expert consultation, and consensus among the writing group, key recommendations are provided. Recommendations reinforce several current practices, including protocol registration; comprehensive search strategies; methods for data extraction and abstraction; methods for identifying, measuring, and dealing with heterogeneity; and statistical methods for pooling results. Other practices should be discontinued, including the use of levels of evidence and evidence hierarchies to gauge the value and impact of different study designs (including meta-analyses) and the use of structured tools to assess the quality of studies to be included in a meta-analysis. We also recommend choosing a pooling model for conventional meta-analyses (fixed effect or random effects) on the basis of clinical and methodological similarities among studies to be included, rather than the results of a test for statistical heterogeneity.
[Mh] Termos MeSH primário: Cardiopatias/prevenção & controle
Cardiopatias/terapia
[Mh] Termos MeSH secundário: American Heart Association
Feminino
Seres Humanos
Masculino
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; META-ANALYSIS; REVIEW
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170925
[Lr] Data última revisão:
170925
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170809
[St] Status:MEDLINE
[do] DOI:10.1161/CIR.0000000000000523



página 1 de 221 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde